Nuvation Bio Inc’s filing revealed that its CEO, ANHEART THERAPEUTICS LTD. Wang Junyuan Jerry unloaded Company’s shares for reported $0.16 million on Nov 11 ’24. In the deal valued at $2.89 per share,56,361 shares were sold. As a result of this transaction, Wang Junyuan Jerry now holds 3,866,228 shares worth roughly $10.32 million.
Then, Mashal Robert bought 100,000 shares, generating $220,000 in total proceeds. Upon buying the shares at $2.20, the Director now owns 100,000 shares.
Before that, Cui Xiangmin bought 277,895 shares. Nuvation Bio Inc shares valued at $825,348 were divested by the Director at a price of $2.97 per share. As a result of the transaction, Cui Xiangmin now holds 2,453,131 shares, worth roughly $6.55 million.
Jefferies upgraded its Nuvation Bio Inc [NUVB] rating to a Buy from a a Hold in a research note published on March 27, 2024; the price target was increased to $10 from $1.40. A number of analysts have revised their coverage, including BTIG Research’s analysts, who increased its forecast for the stock in late March from “a Neutral” to “a Buy”. Jefferies also remained covering NUVB and has decreased its forecast on January 06, 2023 with a “Hold” recommendation from previously “Buy” rating. BTIG Research revised its rating on August 02, 2022. It rated NUVB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NUVB
On Monday, Nuvation Bio Inc [NYSE:NUVB] saw its stock fall -3.96% to $2.67. Over the last five days, the stock has lost -7.61%. Nuvation Bio Inc shares have risen nearly 0.38% since the year began. Nevertheless, the stocks have risen 67.92% over the past one year. While a 52-week high of $4.16 was reached on 01/07/25, a 52-week low of $1.43 was recorded on 01/13/25. SMA at 50 days reached $2.72, while 200 days put it at $2.90.
Levels Of Support And Resistance For NUVB Stock
The 24-hour chart illustrates a support level at 2.51, which if violated will result in even more drops to 2.34. On the upside, there is a resistance level at 2.77. A further resistance level may holdings at 2.86. The Relative Strength Index (RSI) on the 14-day chart is 46.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.34%. Stochastics %K at 33.24% indicates the stock is a holding.
How much short interest is there in Nuvation Bio Inc?
A steep rise in short interest was recorded in Nuvation Bio Inc stocks on 2024-12-31, growing by 6.87 million shares to a total of 20.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 14.07 million shares. There was a rise of 32.8%, which implies that there is a positive sentiment for the stock.
